Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada flag Canada · Delayed Price · Currency is CAD
0.2000
+0.0050 (2.56%)
Mar 28, 2025, 12:16 PM EST
17.65%
Market Cap 25.69M
Revenue (ttm) 1.61M
Net Income (ttm) -5.78M
Shares Out 128.44M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,358
Average Volume 21,177
Open 0.1900
Previous Close 0.1950
Day's Range 0.1900 - 0.2000
52-Week Range 0.1250 - 0.3250
Beta 0.76
RSI 52.71
Earnings Date May 29, 2025

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products.... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mark Upsdell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DOSE
Full Company Profile

Financial Performance

In 2023, Rapid Dose Therapeutics's revenue was 1.02 million, an increase of 42.06% compared to the previous year's 718,298. Losses were -4.31 million, 13.0% more than in 2022.

Financial Statements

News

There is no news available yet.